Promote a Clinical Trial


Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery

The purpose of the study is to assess the efficacy and safety of recombinant von Willebrand factor (rVWF) with or without ADVATE in major and minor elective surgical procedures in adult patients with hereditary severe von Willebrand disease (VWD).

Sponsored by: Baxter Healthcare Corporation